Columbia Care partners with FDA authorized, GMP certified German developer and manufacturer of ultra-higher good quality herbal extracts, organic plant-primarily based mixture supplements and functional beverages with 75-year history of serving the pharmaceutical and meals industries by way of its properly established EU retail network of well being meals retailers, drug retailers, hypermarkets and independent pharmacies
R&D collaboration will present the basis to create a special portfolio of goods combining Columbia Care’s proprietary, pharmaceutical-good quality cannabis-primarily based formulations and Moeller’s deep repository of plant-derived botanical and homeopathic supplements and medicines
NEW YORK–(Organization WIRE)–Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), 1 of the biggest completely integrated operators in the international health-related cannabis sector with licenses across the US and EU, announced that it has entered into an exclusive agreement with Moeller Pharma GmbH (“Moeller”), a GMP-certified German producer of higher-good quality herbal extracts, functional beverages and plant-derived mixture supplements for the pharmaceutical and meals industries, to create a portfolio of proprietary cannabinoid-infused goods to be sold globally, starting with Europe and the US.
Moeller has been a trusted name in German households for much more than 75 years, properly recognized for the production and distribution of more than 100 distinctive higher-good quality fruit juices, plant-primarily based functional drinks, supplements and other goods sold by way of its established network of well being meals retailers, drug retailers and hypermarkets in Europe. By way of its relationships with six of the biggest German wholesalers, Moeller has access to more than 22,000 independent pharmacies and retailers in Germany alone and presently produces much more than 72 special extracts and distillates of medicinal plants at scale for top pharmaceutical businesses. Moeller also possesses considerable production capacity, presently extracting much more than 600 metric tons of biomass per year at its state-of-the-art, FDA authorized, Very good Manufacturing Practice (GMP) certified facility in Germany.
Beneath the terms of the agreement, Columbia Care will contribute its GMP/GAP industrial hemp biomass, chemistry and extraction knowledge as properly as its cannabinoid extraction capabilities for use in well being and wellness goods when Moeller will present its library of plant-primarily based extracts, mixture goods, manufacturing capabilities, distribution channels and expertise in producing common functional customer goods for the international pharmaceutical, wellness and meals markets. The parties will exclusively collaborate on investigation and improvement (R&D) efforts to create a special, patentable portfolio of cannabinoid-infused well being and wellness goods. Completed goods will be manufactured below GMP situations at Moeller’s German manufacturing facility.
“We operate in a international sector and regularly appear for strategies to effectively innovate and leverage current, cannabis and non-cannabis provide and distribution chains. Our partnership with Moeller Pharma gives Columbia Care with access to 1 of the most formidable libraries of plant-primarily based well being and wellness goods in Europe as properly as verified manufacturing and distribution infrastructure that has been inspected and authorized by regulators, which includes in the US. This will permit us to navigate the regulatory and efficiency limitations we presently expertise in the US, when nonetheless providing us access to the US market place by way of our network of licenses,” mentioned Nicholas Vita, chief executive officer of Columbia Care. “Creating extended term, sustainable worth by way of item innovation, distribution and income diversification and international expansion that contains importation into the US, are crucial elements to Columbia Care’s extended-term development technique, and this exclusive arrangement positions us to provide on all 3. Moeller is a trusted, extremely respected international supplement and well being meals brand deemed amongst the highest finish of the well being and wellness marketplace, specifically in the EU. This strategic collaboration positions us to develop into the US by way of each the cannabis and non-cannabis distribution channels by bringing new plant-primarily based goods to the US and the rest of the globe. By combining our current proprietary, pharmaceutical-good quality cannabis-primarily based formulations, extraction abilities and chemistry knowledge with Moeller’s current portfolio of customer goods, special library of plant primarily based extracts and supplements and higher-good quality manufacturing strategies, we appear to expedite the improvement, manufacture and distribution of new, market place top goods that can be sold globally, supporting new and current Columbia Care and Moeller customers’ need to reside a organic, healthful life-style.”
Oliver Hennemann, chief operating officer of Moeller Pharma mentioned, “Columbia Care’s scientific method and concentrate on the patient’s desires has convinced us that it is just the appropriate companion to create our knowledge in establishing revolutionary cannabis goods.” Hennemann continued saying, “Columbia Care’s deep knowledge in cannabis item formulation and Moeller’s industrial scale EU GMP extraction and manufacturing capabilities are a ideal match for accomplishment in this quickly expanding international market place.”
About Columbia Care Inc.
Columbia Care Inc. is 1 of the biggest and most seasoned multi-state operators in the health-related cannabis sector, with licenses in 15 jurisdictions in the US and the EU. With more than 1.two million sales transactions because its inception, Columbia Care is a patient-centered organization setting the regular for compassion, professionalism, good quality, caring and innovation, functioning in collaboration with some of the most renowned and revolutionary teaching hospitals and health-related centers in the globe. The Corporation is committed to delivering the kind of education and transparency sufferers deserve and good quality of item that clinicians count on. For much more info on Columbia Care, please stop by www.col-care.com.
Caution Regarding Forward-Searching Statements
This press release consists of specific statements that constitute forward-hunting info inside the which means of applicable securities laws (“forward-hunting statements”). Statements regarding Columbia Care Inc.’s (“Columbia Care” or the “Company”) objectives, objectives, methods, priorities, intentions, plans, beliefs, expectations and estimates, and the business enterprise, operations, economic efficiency and situation of Columbia Care are forward-hunting statements. The words “believe”, “expect”, “anticipate”, “estimate”, “intend”, “may”, “will”, “would”, “could”, “should”, “continue”, “plan”, “goal”, “objective”, and equivalent expressions and the damaging of such expressions are intended to determine forward-hunting statements, even though not all forward-hunting statements include these identifying words.
Specific material aspects and assumptions had been applied in delivering these forward-hunting statements. Forward-hunting info requires several assumptions which includes the following distinct assumptions: the capacity of Columbia Care to meet its dispensary targets which includes the capacity to negotiate extra lease arrangements satisfactory to the firm, receipt of important permits and regulatory approvals, timely completion of planned building, and the capacity to determine and attract certified employees. Projections may perhaps be impacted by macroeconomic aspects, in addition to other aspects not controllable by the Corporation. Columbia Care has also created specific basic sector assumptions in the preparation of such forward-hunting statements. Management believes that the expectations reflected in forward-hunting statements are primarily based upon affordable assumptions nevertheless, Management can give no assurance that actual benefits will be constant with these forward-hunting statements. Not all aspects which impact the forward-hunting info are recognized, and actual benefits may perhaps differ from the projected benefits in a material respect and may perhaps be above or beneath the forward-hunting info presented in a material respect.
Forward-hunting statements involve recognized and unknown dangers, uncertainties and other aspects that may perhaps bring about Columbia Care’ actual benefits, efficiency or achievements, or developments in its sector, to differ materially from the anticipated benefits, efficiency, achievements or developments expressed or implied by such forward-hunting statements. Provided these uncertainties, readers are cautioned not to spot undue reliance on such forward-hunting statements. When thinking of these forward-hunting statements, readers need to retain in thoughts the danger aspects and other cautionary statements in Columbia Care’s final prospectus dated March 21, 2019 (the “Prospectus”) and filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com. The danger aspects and other aspects noted in the Prospectus could bring about actual events or benefits to differ materially from these described in any forward-hunting info. Forward-hunting statements are primarily based on management’s existing plans, estimates, projections, beliefs and opinions, and Columbia Care does not undertake any obligation to update forward-hunting statements need to assumptions connected to these plans, estimates, projections, beliefs and opinions modify except as needed by applicable securities laws. All of the forward-hunting statements created in this press release are certified by these cautionary statements and other cautionary statements or aspects contained herein, and there can be no assurance that the actual benefits or developments will be realized or, even if substantially realized, that they will have the anticipated consequences to, or effects on, Columbia Care.
Investor Make contact with:
Gary F. Santo, Jr.
Media Make contact with:
Josephine Belluardo, Ph.D.
LifeSci Public Relations